Validation of prostate-specific antigen laboratory values recorded in Surveillance, Epidemiology, and End Results registries

详细信息    查看全文

• 作者：The National Cancer Institute Surveillance ; Epidemiology ; and End Results Prostate-Specific Antigen Working Group ; Margaret (Peggy) Adamo ; Jessica A. Boten ; Linda M. Coyle ; Kathleen A. Cronin ; Clara J. K. Lam ; Serban Negoita ; Lynne Penberthy ; Jennifer L. Stevens and Kevin C. Ward
• 刊名：Cancer
• 出版年：2017
• 出版时间：February 15, 2017
• 年：2017
• 卷：123
• 期：4
• 页码：697-703
• 全文大小：102K
• ISSN：1097-0142

文摘

Researchers have used prostate-specific antigen (PSA) values collected by central cancer registries to evaluate tumors for potential aggressive clinical disease. An independent study collecting PSA values suggested a high error rate (18%) related to implied decimal points. To evaluate the error rate in the Surveillance, Epidemiology, and End Results (SEER) program, a comprehensive review of PSA values recorded across all SEER registries was performed.